1. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells
    Christian Mayr et al, 2015, BMC Complement Altern Med CrossRef
  2. Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma
    Massimiliano Cadamuro et al, 2017, IJMS CrossRef
  3. Expression of CD24 in Human Bone Marrow-Derived Mesenchymal Stromal Cells Is Regulated by TGFβ3 and Induces a Myofibroblast-Like Genotype
    Luisa Marilena Schäck et al, 2016, Stem Cells International CrossRef
  4. Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness
    Ying Xie et al, 2016, Mol. Pharmaceutics CrossRef
  5. Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers
    Christian Mayr et al, 2016, BioMed Research International CrossRef
  6. Biliary tract cancer stem cells - translational options and challenges.
    Tobias Kiesslich, 0 CrossRef
  7. Molecular mechanisms of cholangiocarcinoma cell inhibition by medicinal plants
    Surang Leelawat et al, 2017 CrossRef
  8. Clinicopathological and Prognostic Value of CD24 Expression in Breast Cancer: A Meta-Analysis
    Gao Liu et al, 2017, The International Journal of Biological Markers CrossRef
  9. The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer
    Su Jin Lee et al, 2018, Translational Oncology CrossRef
  10. Etiology and Pathogenic Pathways of Cholangiocarcinoma
    Arthur Zimmermann, 2016 CrossRef
  11. The role of polycomb repressive complexes in biliary tract cancer
    Christian Mayr et al, 2015, Expert Opinion on Therapeutic Targets CrossRef
  12. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway
    Shengqiang Zhao et al, 2014, J Exp Clin Cancer Res CrossRef
  13. Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine
    CHRISTIAN MAYR et al, 2015 CrossRef
  14. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications
    Hsing-Ju Wu et al, 2019, IJMS CrossRef
  15. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?
    Maurizio Romano et al, 2016, J. Cell. Physiol CrossRef
  16. CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro.
    Zhen Pei et al, 2016, Oncol. Rep. CrossRef
  17. Etiology and Pathogenic Pathways of Cholangiocarcinoma
    Arthur Zimmermann, 2017 CrossRef
  18. The CD24 surface antigen in neural development and disease
    Daniel T. Gilliam et al, 2017, Neurobiology of Disease CrossRef
  19. Nicotine Promotes Cholangiocarcinoma Growth in Xenograft Mice
    Allyson K. Martínez et al, 2017, The American Journal of Pathology CrossRef
  20. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
    Ashraf Mousavi, 2019, Immunology Letters CrossRef
  21. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
    Christian Mayr et al, 2016, Oncotarget CrossRef
  22. Novel insights into the function of CD24 : A driving force in cancer
    Peter Altevogt et al, 2020, Int. J. Cancer CrossRef
  23. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines
    Jiaqi Yang et al, 2020, Annals of Hepatology CrossRef
  24. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy
    Yang-Hong Ni et al, 2020, CGT CrossRef
  25. The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas
    Margaretha A. Skowron et al, 2021, Mol Oncol CrossRef
  26. Current Status of 68Ga-Pentixafor in Solid Tumours
    Bawinile Hadebe et al, 2022, Diagnostics CrossRef
  27. Antitumor activities of a novel fluorinated small molecule (A1) in CT26 colorectal cancer cells: molecular docking and in vitro studies
    Hossein Khorramdelazad et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef